Two or three years ago, people in biotech would have said you were nuts if you had predicted a revival of cancer immunotherapy. Dendreon, the Seattle-based trailblazer, had its well-documented stumbles in the marketplace. But researchers have never been more excited about the various ways of harnessing the immune system to kill cancer cells. Enthusiasm was stirred by a series of groundbreaking presentations at medical meetings in 2013, and one of the richest biotech startup financings in industry history (Seattle-based Juno Therapeutics). Come hear from leading scientists and entrepreneurs from around the country who can candidly discuss the opportunities, and challenges, in this emerging field.
Hans Bishop, CEO, Juno Therapeutics
Teresa Foy, CSO, Oncofactor Corporation
Mitch Gold, Executive Chairman, Alpine BioSciences
Rob Hershberg, CEO, VentiRx Pharmaceuticals
Deborah Law, VP, Biologics Discovery, Merck
Ira Mellman, VP, Cancer Immunology, Genentech
Robert Nelsen, Managing Director, Arch Venture Partners
Martin Oft, VP, Clinical and Regulatory Affairs, ARMO BioSciences
Stan Riddell, Researcher, Fred Hutchinson Cancer Research Center
Chad Robins, CEO, Adaptive Biotechnologies
Registration & Networking: 2:00 - 2:45 pm
Program: 2:45 - 5:45 pm
Networking reception: 5:45 - 7:00 pm
Tickets are transferable but not refundable.
To inquire about press registration, email email@example.com.
Alexandria Real Estate Equities
Cooley LLP •
Christensen O'Connor Johnson Kindness •
Davis Wright Tremaine
Fenwick & West • Genentech • Institute for Systems Biology
Kauffman Foundation • Kilpatrick Townsend
VENTURE CAPITAL MEMBERS
ARCH Venture Partners • WRF Capital
LIFE SCIENCE MEMBERS
Alnylam Pharmaceuticals • Infinity Pharmaceuticals • Ironwood Pharmaceuticals
Moderna Therapeutics • Sarepta Therapeutics
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.